Zobrazeno 1 - 10
of 29
pro vyhledávání: '"S A, Cannistra"'
Publikováno v:
Blood. 80:2306-2314
In multiple myeloma, malignant plasma cells are localized in marrow and rarely circulate in peripheral blood. To investigate the role of adhesion proteins in this process, we determined the expression and function of adhesion molecules on cell lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb6d676147d338c8a6077cc214afd602
https://doi.org/10.1182/blood.v80.9.2306.bloodjournal8092306
https://doi.org/10.1182/blood.v80.9.2306.bloodjournal8092306
Publikováno v:
Cancer research. 59(9)
The BAX proapoptotic protein is capable of inducing cell death either directly, through its effects on mitochondrial function, or indirectly, by lowering the apoptotic threshold in response to certain chemotherapy agents. In this study, we tested the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::df7d71486ec875e4b038f1ffea2a32cc
https://pubmed.ncbi.nlm.nih.gov/10232598
https://pubmed.ncbi.nlm.nih.gov/10232598
Publikováno v:
Cancer research. 58(21)
SW626 cells that overexpress BAX are sensitized to the cytotoxic effects of paclitaxel and vincristine. It has been assumed that BAX mediates these effects through its ability to alter mitochondrial function, specifically by promoting the release of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ab6bb93b4e2e5a1eae9910457432b86
https://pubmed.ncbi.nlm.nih.gov/9809975
https://pubmed.ncbi.nlm.nih.gov/9809975
Autor:
D, Fink, S, Nebel, P S, Norris, R N, Baergen, S P, Wilczynski, M J, Costa, M, Haas, S A, Cannistra, S B, Howell
Publikováno v:
International journal of cancer. 77(5)
In addition to playing a role in tumorigenesis, loss of DNA mismatch repair results in low-level intrinsic resistance to cisplatin and carboplatin. We used a mismatch repair-deficient (clone B) and -proficient (clone B/rev) pair of Chinese hamster ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8abfd0a4025496a67ab59b35ed8066b3
https://pubmed.ncbi.nlm.nih.gov/9688308
https://pubmed.ncbi.nlm.nih.gov/9688308
Publikováno v:
Cancer research. 57(7)
Ovarian cancer cells frequently metastasize by implanting onto the peritoneal mesothelial lining of the abdominal cavity. Data obtained from in vitro adhesion studies have suggested a possible role for the CD44 molecule in this process. The purpose o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0b744ba23dd3513b02a7e9f0c40d7f8e
https://pubmed.ncbi.nlm.nih.gov/9102203
https://pubmed.ncbi.nlm.nih.gov/9102203
Publikováno v:
Gynecologic oncology. 58(2)
Ovarian cancer cells disseminate by implanting onto the peritoneal mesothelial cell surface of the abdominal cavity. A common feature of these peritoneal implants is the presence of tumor cell invasion into the submesothelial extracellular matrix (EC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::242fd70d55931badf4b586116b74da4c
https://pubmed.ncbi.nlm.nih.gov/7542622
https://pubmed.ncbi.nlm.nih.gov/7542622
Autor:
S A, Cannistra
Publikováno v:
Gynecologic oncology. 51(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5f9584896f43a1610607b94404fec69a
https://pubmed.ncbi.nlm.nih.gov/8276314
https://pubmed.ncbi.nlm.nih.gov/8276314
Publikováno v:
Blood. 79(3)
One of the mechanisms by which normal hematopoietic progenitor cells remain localized within the bone marrow microenvironment is likely to involve adhesion of these cells to extracellular matrix (ECM) proteins. For example, there is evidence that unc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ecf74244b284768af5f809ed1552d1d2
https://pubmed.ncbi.nlm.nih.gov/1370640
https://pubmed.ncbi.nlm.nih.gov/1370640
Autor:
S. A. Cannistra, J. DiCarlo, P. Groshek, Y. Kanakura, D. Berg, R. Stone, R. J. Mayer, J. D. Griffin
Publikováno v:
Acute Leukemias ISBN: 9783540539490
Patients with refractory or relapsed acute myeloid leukemia (AML) are often treated with regimens containing high-dose cytosine arabinoside (ARA-C), resulting in complete response rates of approximately 30% to 50%, with a median remission duration of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51e3e538eba93079479801d856a4b657
https://doi.org/10.1007/978-3-642-76591-9_18
https://doi.org/10.1007/978-3-642-76591-9_18
Publikováno v:
Leukemia. 5(3)
The treatment of patients with relapsed or refractory acute myeloid leukemia (AML) with high dose cytosine arabinoside (ara-C) results in short-lived complete response rates of 30-50%. We have previously shown that entry of myeloid leukemic cells int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1db6cd1fdf52daafe7d526357537867f
https://pubmed.ncbi.nlm.nih.gov/1826536
https://pubmed.ncbi.nlm.nih.gov/1826536